# FDA Warning Letter: Hangzhou Huiji Biotechnology Co., Ltd.
> 2024-11-26 · Center for Drug Evaluation and Research (CDER) · `6be9bcf23cdf2784`
## Letter
- **Company:** Hangzhou Huiji Biotechnology Co., Ltd.
- **Posted Date:** 2024-11-26
- **Letter Issue Date:** 2024-11-18
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*